A patient medication package stored in an institutional setting where the storage and handling of the drugs are assured and are consistent with the compendia standards may be returned to the pharmacy stock provided the which of following conditions are met?

I. the drug is to be kept within the patient medication package and it is to remain sealed and labeled until dispensed.

II. the expiration date of drug shall become 50% of the time left of the expiration for the drug.

III. no Schedule II, III or IV drugs may be returned to inventory.

a. I only
b. I and II only
c. II and III only
d. All

Answer:

  Answer  

A patient medication package stored in an institutional setting where the storage and handling of the drugs are assured and are consistent with the compendia standards may be returned to the pharmacy stock provided the which of following conditions are met?

I. the drug is to be kept within the patient medication package and it is to remain sealed and labeled until dispensed.

II. the expiration date of drug shall become 50% of the time left of the expiration for the drug.

III. no Schedule II, III or IV drugs may be returned to inventory.

a. I only
b. I and II only
c. II and III only
d. All

Answer: I and II only, [New Mexico Administrative Code (NMAC) 16.19.4.11(B)(p)].

Patient medication packages with more than one drug within a container may not under any circumstances be returned to a pharmacy stock.

Patient Medication Package's with only one drug within a container:

(1). Non-Institutional: A patient medication package stored in a non-institutional setting where there is no assurance of storage standards may NOT be returned to pharmacy stock.

(2). Institutional: A patient medication package stored in an institutional setting where the storage and handling of the drugs are assured and are consistent with the compendia standards may be returned to the pharmacy stock provided the following guidelines are followed:

(a). the drug is to be kept within the patient medication package and it is to remain sealed and labeled until dispensed;

(b). the expiration date of drug shall become 50% of the time left of the expiration for the drug;

(c). no Schedule II drugs (Schedule III, IV and V are allowed) may be returned to inventory; and

(d). proper record keeping for the addition of other scheduled drugs into inventory must be done.

  Close  

A pharmacy permit holder shall maintain current computerized records in a manner which permits reconstruction within 72 hours of the request by the Board.

True or False

  Answer  

A pharmacy permit holder shall maintain current computerized records in a manner which permits reconstruction within 72 hours of the request by the Board.

False, [Department of Health and Mental Hygiene 10.34.05.04(A)(3)].

A. A pharmacy permit holder shall:

(1). Prevent unauthorized disclosure or loss by securing all patient records;

(2). Designate personnel with authorized access to computerized patient records; and

(3). Maintain current computerized records in a manner which permits reconstruction within 48 hours, except:

(a). In an emergency as defined in Regulation .01 of this chapter, or

(b). With the prior approval of the Board.

B. A pharmacy permit holder may store patient records away from the prescription area in a manner that prevents unauthorized disclosure or loss.

  Close  

Unless the licensed pharmacist has reason to reduce the time period, the expiration date of the PRE-PACKAGED medication is the lesser of:

I. 6 months from the date of packaging

II. The manufacturer’s or distributor’s listed expiration date

III. The maximum time period allowed for the specific packaging used for the medication

a. I only
b. I and II only
c. II and III only
d. All

Answer:

  Answer  

Unless the licensed pharmacist has reason to reduce the time period, the expiration date of the PRE-PACKAGED medication is the lesser of:

I. 6 months from the date of packaging

II. The manufacturer’s or distributor’s listed expiration date

III. The maximum time period allowed for the specific packaging used for the medication

a. I only
b. I and II only
c. II and III only
d. All

Answer:II and III only, [Department of Health and Mental Hygiene 10.34.03.09]. Unless the licensed pharmacist has reason to reduce the time period, the expiration date of the medication is the lesser of:

(1). Twelve (Not Six) months from the date of packaging;
(2). The manufacturer’s or distributor’s listed expiration date; or
(3). The maximum time period allowed for the specific packaging used for the medication.

  Close  

Buprenorphine is classified as a Schedule V controlled drug under the West Virginia State Pharmacy Law. It can be sold Over The Counter to a patient.

True or False

  Answer  

Buprenorphine is classified as a Schedule V controlled drug under the West Virginia State Pharmacy Law. It can be sold Over The Counter to a patient.

Answer: False, [Uniform Controlled Substances Act 60A-3-308(d)(1)].

A controlled substance included in Schedule V shall not be distributed or dispensed other than for a medicinal purpose: Provided, That buprenorphine shall be dispensed only by a prescription.

  Close  

A pharmacist may compound or dispense any prescription order when he or she has knowledge that the prescription was issued by a practitioner on the basis of an online or telephonic consultation.

True or False

  Answer  

A pharmacist may compound or dispense any prescription order when he or she has knowledge that the prescription was issued by a practitioner on the basis of an online or telephonic consultation.

Answer: False, [[West Virginia Code Chapter 30 Section 30-5-14].

A pharmacist may not compound or dispense any prescription order when he or she has knowledge that the prescription was issued by a practitioner without establishing a valid practitioner-patient relationship.

An online or telephonic evaluation by questionnaire, or an online or telephonic consultation, is inadequate to establish a valid practitioner-patient relationship:

Provided, That this prohibition does not apply:

(1). In a documented emergency;

(2). In an on-call or cross-coverage situation; or

(3). Where patient care is rendered in consultation with another practitioner who has an ongoing relationship with the patient and who has agreed to supervise the patient's treatment, including the use of any prescribed medications.

  Close  

According to Michigan State Pharmacy Law, the automated dispensing system can be used as an after-hours cabinet for medication dispensing in the absence of a pharmacist in institutions.

True or False

  Answer  

According to Michigan State Pharmacy Law, the automated dispensing system can be used as an after-hours cabinet for medication dispensing in the absence of a pharmacist in institutions.

True, [Michigan Pharmacy- Controlled Substances Act 338.3154 Rule 54 (11)].

Normally, the automated device shall include a requirement for pharmacist review of the prescription or medication order before system profiling or removal of any medication from the system for immediate patient administration. However this subsection do not apply to the following situations:

(a). The system is being used as an after-hours cabinet for medication dispensing in the absence of a pharmacist.

(b). The system is being used in place of an emergency kit as provided in R 338.486(4)(c).

(c). The system is being accessed to remove medication required to treat the emergent needs of a patient as provided in R 338.486(4)(c). A sufficient quantity to meet the emergent needs of the patient may be removed until a pharmacist is available to review the medication order.

(d). In each of the situations specified in subdivisions (a) to (c) of this subrule, a pharmacist shall review the orders and authorize any further dispensing within 48 hours.

A copy of all pharmacy policies and procedures related to the use of an automated device shall be maintained at the pharmacy responsible for the device's specific location and be available for review by an agent of the board.

  Close  

A licensee shall keep and make available for inspection all records for controlled substances, including:

I. Invoices
II. Acquisition records.
III. Sales receipts

a. I only
b. I and II only
c. II and III only
d. All

Answer:

  Answer  

A licensee shall keep and make available for inspection all records for controlled substances, including:

I. Invoices
II. Acquisition records.
III. Sales receipts

a. I only
b. I and II only
c. II and III only
d. All

Answer: (b), [Michigan PHARMACY, GENERAL RULES 338.3153 (Rule 53)(1)].

A licensee shall keep and make available for inspection all records for controlled substances, including invoices and other acquisition records, but excluding sales receipts, however a copy of each receipt shall be retained for 90 days.

  Close  

“Marijuana” means:

I. The seeds of plant of the genus Cannabis.
II. The resin extracted from plant of the genus Cannabis.
III. The mature stems of the plant of the genus Cannabis.

a. I only
b. I and II only
c. II and III only
d. All

Answer:

  Answer  

“Marijuana” means:

I. The seeds of plant of the genus Cannabis.
II. The resin extracted from plant of the genus Cannabis.
III. The mature stems of the plant of the genus Cannabis.

a. I only
b. I and II only
c. II and III only
d. All

Answer: (b) I and II only, [Nevada Revised Statues 453.096].

"Marijuana" means:

(a). All parts of any plant of the genus Cannabis, whether growing or not;
(b). The seeds thereof;
(c). The resin extracted from any part of the plant; and
(d). Every compound, manufacture, salt, derivative, mixture or preparation of the plant, its seeds or resin.

2. "Marijuana" does not include the mature stems of the plant, fiber produced from the stems, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture or preparation of the mature stems (except the resin extracted therefrom), fiber, oil or cake, or the sterilized seed of the plant which is incapable of germination.

  Close  

If the managing pharmacist is the only registered pharmacist employed in the pharmacy, the Board may authorize his or her absence each day for a total period of not to exceed 2 hours for the purpose of taking meals if:

I. A registered pharmacist is on call during the absence.
II. A sign is posted for public view in the pharmacy indicating the absence of the pharmacist and the hours of the absence.
III. The authorization required from the Board must be in writing and be retained in the pharmacy and available for inspection.

a. I only
b. I and II only
c. II and III only
d. All

Answer:

  Answer  

If the managing pharmacist is the only registered pharmacist employed in the pharmacy, the Board may authorize his or her absence each day for a total period of not to exceed 2 hours for the purpose of taking meals if:

I. A registered pharmacist is on call during the absence.
II. A sign is posted for public view in the pharmacy indicating the absence of the pharmacist and the hours of the absence.
III. The authorization required from the Board must be in writing and be retained in the pharmacy and available for inspection.

a. I only
b. I and II only
c. II and III only
d. All

Answer: (d) All, [Nevada Revised Statues 639.220(2)].

If the managing pharmacist is the only registered pharmacist employed in the pharmacy, the Board may authorize his or her absence each day for a total period of not to exceed 2 hours for the purpose of taking meals if:

a. A registered pharmacist is on call during the absence.

b. A sign is posted for public view in the pharmacy indicating the absence of the pharmacist and the hours of the absence.

c. All drugs, poisons, chemical and restricted devices are kept safe in a manner prescribed by regulations of the Board.

d. The authorization required from the Board must be in writing and be retained in the pharmacy and available for inspection.

  Close  

Prior to prescribing, administering, dispensing, ordering, selling, supplying, or giving a Schedule III or IV amphetamine-like controlled substance to treat obesity in a patient sixteen (16) years of age or older, the physician shall obtain and review:

a. JNC Obesity Guidelines
b. CDCP Report
c. KASPER Report
d. DNPAO Guidelines

Answer:

  Answer  

Prior to prescribing, administering, dispensing, ordering, selling, supplying, or giving a Schedule III or IV amphetamine-like controlled substance to treat obesity in a patient sixteen (16) years of age or older, the physician shall obtain and review:

a. JNC Obesity Guidelines
b. CDCP Report
c. KASPER Report
d. DNPAO Guidelines

Answer:(c). Kentucky All Schedule Prescription Drug Electronic Reporting System (KASPER) report, [201 KAR 9:016 Section 4].

(1). Prior to prescribing, administering, dispensing, ordering, selling, supplying, or giving a Schedule III or IV amphetamine-like controlled substance to treat obesity in a patient sixteen (16) years of age or older, the physician shall:

(a). Establish a physician/patient relationship;

(b). Determine that the patient is obese or overweight with medical risk factors and is a proper candidate for weight reduction treatment;

(c). Determine and record the extent of prior anorectics or other controlled substances used by the patient.

The prescribing physician shall obtain and review a KASPER report for the twelve (12) month period immediately preceding the patient encounter, before prescribing or dispensing controlled substances to the patient.

(2). During treatment for obesity, a physician shall:

(a). Maintain a physician/patient relationship throughout the treatment process;

(b). Maintain an adequate patient record in accordance with subsection (4) of this section; and

(c). Justify in the patient record the use of any Schedule III or IV amphetamine-like controlled substance beyond three (3) months.

Before the physician continues the use of a substance beyond three (3) months, the physician shall obtain and review a current KASPER report.

  Close